在淋巴细胞恶性瘤中准乌比奎丁途径
Boheng Li1, Pieter Johan Adam Eichhorn2, Wee-Joo Chng3
1College of Pharmaceutical Sciences, Southwest University, Chongqing, China.
Cancer letters
|May 25, 2024
概括
在细胞生物学中至关重要的基化在淋巴状癌症中发生变化. 针对异常的无处不在途径和使用新型分子为这些疾病提供了有前途的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 癌症生物学 癌症生物学
- 生物化学 生物化学
背景情况:
- 化是一种重要的细胞过程,涉及到许多生物功能.
- 无处不在途径的失调越来越被认为是各种疾病,特别是癌症的驱动因素.
- 在了解在淋巴细胞恶性瘤中无处可见的作用方面取得了重大进展.
研究的目的:
- 在淋巴状癌症中,审查因E2s/E3酶和duebiquitinating酶 (DUBs) 改变表达而导致的异常信号传导机制.
- 讨论当前和新兴的治疗策略,以向淋巴细胞恶性瘤中的泛化系统.
- 突出异构生物功能分子在调节蛋白质稳定性和降解方面的潜力.
主要方法:
- 对近期关于淋巴状癌症中无处不在的研究的文献综述.
- 分析受异常E2s/E3s和DUBs表达影响的信号通路.
- 检查针对无素-蛋白酶体系统的治疗干预措施.
主要成果:
- 异常表达E2s/E3s和DUBs导致coprotein过活化或瘤抑制剂下调.
- 治疗策略的目的是阻止异常的无素-蛋白酶体通路.
- 正在开发异构功能分子,以向非同源基质进行降解或稳定.
结论:
- 了解淋巴细胞癌中的无处不在异常对于开发有效的治疗方法至关重要.
- 针对无处不在的系统,包括新的分子方法,显示出显著的治疗潜力.
- 需要进一步的研究,以充分阐明ubiquitination和淋巴细胞病原体之间的联系,以改善临床干预.
关键词:
脱基化酶 (DUB) 是一种免疫调节剂 (IMiD) 是一种免疫调节剂.淋巴瘤是一种淋巴瘤.多发性骨髓瘤 (MM) 是一种多发性骨髓瘤.蛋白质酶抑制剂 (PI) 是一种蛋白质酶抑制剂.在Ubiquitination中使用.更多相关视频
10:26Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations
Published on: November 7, 2019
5.6K
10:43siRNA Screening to Identify Ubiquitin and Ubiquitin-like System Regulators of Biological Pathways in Cultured Mammalian Cells
Published on: May 24, 2014
11.4K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:31The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
01:27Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515